ribosomal protein L10a pseudogene 2 (RPL10AP2)

RPL10AP2 (ribosomal protein L10a pseudogene 2) is a processed pseudogene in the human genome arising from the parent ribosomal protein L10A gene, but it does not encode a functional protein[5][4]. Like most ribosomal protein pseudogenes, it is the result of mRNA retrotransposition and is present in the genome as a noncoding segment[6]. Although pseudogenes have historically been considered “junk DNA,” some may act as regulators of gene expression by serving as sources of noncoding RNA that can repress cognate protein-coding genes or compete for microRNA binding, indirectly influencing cellular health and disease[6][10]. There is no evidence for protein expression, therapeutic relevance, or direct drug interaction concerning RPL10AP2. It is not a receptor, enzyme, transporter, or transcription factor, and querying it as a target for drug discovery would be incorrect. If more specific structured information about the protein-coding parent gene (ribosomal protein L10a; RPL10A) is needed, that should be queried directly. RPL10AP2 itself should be treated as a noncoding pseudogene with potential emergent regulatory roles, but no disease or drug target status[5][6].

Other names

RPL10AP2RPL10A_5_900

None directly applicable; mechanisms described for pseudogenes relate to regulatory RNA effects, not drug action